These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21745005)

  • 1. Primary central nervous system lymphoma: the challenge continues.
    Wirth A
    Leuk Lymphoma; 2011 Nov; 52(11):2037-8. PubMed ID: 21745005
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
    Motomura K; Natsume A; Fujii M; Ito M; Momota H; Wakabayashi T
    Leuk Lymphoma; 2011 Nov; 52(11):2069-75. PubMed ID: 21745167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for Primary CNS Lymphoma.
    Laghari AA; Ahmed SI; Jabbar A; Shamim MS
    J Pak Med Assoc; 2018 Mar; 68(3):499-500. PubMed ID: 29540898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Villa E
    Cancer Treat Rev; 1995 Sep; 21(5):415-46. PubMed ID: 8556717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of primary central nervous system lymphoma.
    Royer-Perron L; Hoang-Xuan K
    Presse Med; 2018; 47(11-12 Pt 2):e213-e244. PubMed ID: 30416008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in the treatment of primary central nervous system lymphoma].
    Nakamaki T
    Brain Nerve; 2014 Aug; 66(8):969-79. PubMed ID: 25082318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment approaches for primary CNS lymphomas.
    Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
    Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies of primary CNS lymphomas and oligodendrogliomas.
    Macdonald DR
    J Neurooncol; 1995; 24(1):97-101. PubMed ID: 8523084
    [No Abstract]   [Full Text] [Related]  

  • 10. Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.
    Yamanaka R; Homma J; Sano M; Tsuchiya N; Yajima N; Shinbo Y; Hasegawa A; Onda K; Tanaka R
    Leuk Lymphoma; 2007 May; 48(5):1019-22. PubMed ID: 17487746
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary central nervous system lymphoma after liver transplantation treated by radiosurgery combined with fractionated radiotherapy.
    Kim MS; Lee JI; Kim WS; Ko YH
    J Clin Neurosci; 2009 Apr; 16(4):583-5. PubMed ID: 19200738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system cancers: Clinical Practice Guidelines in Oncology.
    Brem SS; Bierman PJ; Black P; Blumenthal DT; Brem H; Chamberlain MC; Chiocca EA; DeAngelis LM; Fenstermaker RA; Fine HA; Friedman A; Glass J; Grossman SA; Heimberger AB; Junck L; Levin V; Loeffler JJ; Maor MH; Narayana A; Newton HB; Olivi A; Portnow J; Prados M; Raizer JJ; Rosenfeld SS; Shrieve DC; Sills AK; Spence AM; Vrionis FD;
    J Natl Compr Canc Netw; 2005 Sep; 3(5):644-90. PubMed ID: 16194456
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissociated evolution of a multifocal primary CNS lymphoma.
    Bagacean C; Zdrenghea M; Popescu C; Quintin-Roue I; Ianotto JC; Eveillard JR; Berthou C; Tempescul A
    J BUON; 2013; 18(4):1098. PubMed ID: 24344046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Not Available].
    Hoang-Xuan K
    Bull Acad Natl Med; 2015 Nov; 199(8-9):1331. PubMed ID: 29874422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary central nervous lymphoma: what is the role for radiotherapy?].
    Bellefqih S; Mezouri I; Khalil J; Bazine A; Diakité A; El Kacimi H; Kebdani T; Benjaafar N
    Cancer Radiother; 2014 Nov; 18(7):685-92. PubMed ID: 25451676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials at the medicine branch of the NCI-part 2.
    Cheson BD; Wilson WH; Phillips PH
    Oncology (Williston Park); 1995 Jun; 9(6):506, 509-10. PubMed ID: 8719096
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of secondary central nervous system lymphoma.
    Cwynarski K; Cummin T; Osborne W; Lewis J; Chaganti S; Smith J; Linton K; Greaves P; McKay P; Fox CP;
    Br J Haematol; 2023 Jan; 200(2):160-169. PubMed ID: 36408800
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
    Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
    Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.